Trials / Completed
CompletedNCT05600179
OCTA in Epivascular Glia After Dex Implant
Evaluation of Changes in Epivascular Glia Before and After Intravitreal Dexamethasone Implant : an OCT Pilot Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 38 (actual)
- Sponsor
- Federico II University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
The aim of this prospective study was for the first time, to analyze specific morphologic features in diabetic eyes with macular oedema, such as changes of the foveal avascular zone and the presence of epivascular glia, and see how they would change after dexamethasone intravitreal implant
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dexamethasone intravitreal implant | Dexamethasone intravitreal implant |
Timeline
- Start date
- 2021-01-01
- Primary completion
- 2022-09-30
- Completion
- 2022-09-30
- First posted
- 2022-10-31
- Last updated
- 2022-12-08
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT05600179. Inclusion in this directory is not an endorsement.